DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/7j5vvs/top_1000) has announced the addition of the "Top 1000 Pharmaceutical Wholesalers (Global)" report to their offering.
This report is an in-depth financial evaluation of the Global Pharmaceutical Wholesalers. Using the unique Plimsoll method of analysis, each of the top 1000 companies included is individually assessed and ranked against each other and compared to industry averages. Using the most up-to-date financial information available, the two-page per company analysis provides detailed financial analysis for each organisation.
The following are some of the key findings of this new report:
- 83 of the 1000 companies analysed have been rated as Danger
- 132 companies are ripe for takeover
- 109 companies achieved greater than 10% increase in sales last year
- 70 companies made a pre-tax loss
- 280 companies saw sales fall last year
Our analysis gives you this unrivalled market and company intelligence using a simple graphical, numeric and model. Each company is individually analysed in both the company's own currency, and USD ($) for ease of use. These individual analyses highlight a company's strengths and weaknesses instantly.
Along with individual company information, this report also contains a comprehensive study of the market, based on the companies analysed.
This key information includes:
- Best trading partners (based on commercial and financial strength)
- Sales growth (highest sales, growth rate, size of market based on the companies analysed, average growth)
- Profitability (Profit return on assets, pre-tax profit margins, industry average)
- Fastest growing companies (performance matrix)
Key Topics Covered:
This extensive report is broken into two parts:
1. A complete financial assessment of the market, based on the companies analysed
2. An individual financial performance analysis of each company (2 pages per company)
Specific areas included in the market assessment include;
Section 1 - Best Trading Partners (based on commercial and financial strength)
Section 2 - Sales & Market Performance
Section 3 - Profitability
4.0 - How to Use
5.0 - Individual Company Analysis
For more information visit http://www.researchandmarkets.com/research/7j5vvs/top_1000
Source: Research and Markets